ReNeuron is a Wales-based biotechnology company that develops and commercializes stem cell therapies for the treatment of eye diseases.
Business Model:
Revenue: $589.3k
Employees: 11-50
Address: 10 Nugent Rd
City: Bridgend
State: wales
Zip: CF35 5HY
Country: GB
ReNeuron is a Wales-based biotechnology company that develops and commercializes stem cell therapies for the treatment of eye diseases.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
8/12/2005
Ticker Symbol:
RENE
IPO Price:
$0.4536620508065204/share
Amount Raised:
$17M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2015 | Equity | $105.2M | 1/1997 | Venture Round | 1 | $7.5M |
Excalibur Fund Managers Excalibur Fund Managers Excalibur Fund Managers Excalibur Fund Managers |
5/2010 | Unattributed | $7.3M | 11/2009 | Post-IPO Equity | 1 | $7.5M |
Matrix Corporate Capital Matrix Corporate Capital Matrix Corporate Capital Matrix Corporate Capital |
2/2010 | Post-IPO Equity | $6.4M | 7/2013 | Post-IPO Equity | 1 | $38.9M |
Arthurian Life Sciences Arthurian Life Sciences |
4/2018 | Grant | $2.1M | 7/2015 | Post-IPO Equity | 1 | $106.1M |
Woodford Investment Management Woodford Investment Management Woodford Investment Management Woodford Investment Management |
---|
Announced Date | Name | Price |
---|---|---|
7/2007 | AmCyte |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|